Y-Intercept (HK)’s Haemonetics HAE Stock Holding History

Y-Intercept (HK)’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-51,334	Closed	-$2.89M	–	1901
2026 Q1	$2.89M	Buy	51,334 +28,586	+126%	+$1.86M	0.05%	546
2025 Q4	$1.82M	Sell	22,748 -24,115	-51%	-$1.62M	0.04%	664
2025 Q3	$2.28M	Buy	+46,863	New	+$2.9M	0.05%	536
2024 Q4	–	Sell	-4,752	Closed	-$382K	–	1379
2024 Q3	$382K	Buy	+4,752	New	+$384K	0.02%	910
2024 Q1	–	Sell	-4,669	Closed	-$399K	–	1526
2023 Q4	$399K	Buy	+4,669	New	+$404K	0.04%	708
2023 Q3	–	Sell	-4,613	Closed	-$393K	–	1254
2023 Q2	$393K	Buy	4,613 +1,217	+36%	+$103K	0.04%	665
2023 Q1	$281K	Buy	+3,396	New	+$275K	0.03%	811
2022 Q2	–	Sell	-6,551	Closed	-$414K	–	982
2022 Q1	$414K	Buy	+6,551	New	+$356K	0.09%	339

Other funds holding HAE

RRAM

River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

PCM

Peregrine Capital Management Minneapolis, Minnesota $3.08B AUM 29.51% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

CIM

Confluence Investment Management St. Louis, Missouri $6.4B AUM 9.79% 1-Year Est. Return

HPCM

Hunter Perkins Capital Management Lombard, Illinois $446M AUM 25.88% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

YCM

Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Y-Intercept (HK)'s HAE Position: Q2 2026 in Review

Y-Intercept (HK) sold out of Haemonetics (HAE) in Q2 2026, closing a stake of 51,334 shares — an estimated $2.89M sold.

Y-Intercept (HK) first reported a position in HAE in Q1 2022 and held it in 8 quarters. The position peaked at $2.89M in Q1 2026. 31 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

Y-Intercept (HK) reported no remaining Haemonetics position as of Q2 2026 after selling out during the quarter.
Y-Intercept (HK) sold 51,334 Haemonetics shares in Q2 2026, an estimated $2.89M.
Y-Intercept (HK) first reported a position in Haemonetics in Q1 2022 and held it in 8 quarters.
Y-Intercept (HK)'s Haemonetics position peaked at $2.89M in Q1 2026.
31 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Y-Intercept (HK)'s 13F filing for Q2 2026, filed 14 Jul 2026.